Conference Coverage

Mild cognitive impairment rises in heart patients with comorbidities


 

REPORTING FROM THE AHA SCIENTIFIC SESSIONS

The 2,161 subjects, mean age 70 years and two-thirds male, ranged across the full spectrum of cardiovascular disease, from mild to severe. All were screened for MCI by completing the Montreal Cognitive Assessment, or MoCA. A MoCA score below 26 out of a possible 30 is defined as MCI.

Bruce Jancin/Frontline Medical News

Dr. Jocasta Ball

Forty-seven percent of subjects had MCI. They were older, with a mean age of 73 years versus 67 years; were more likely to have a history of stroke, by a margin of 20% versus 12%; had a 52% prevalence of atrial fibrillation versus 44%; and had a 50% prevalence of heart failure versus 39% in subjects with normal cognition. In addition, 48% of the MCI group screened positive for depressive symptoms versus 37% of those without MCI, and 28% of patients with MCI had type 2 diabetes, compared with 22% of those without MCI. Renal disease was also significantly more prevalent in the MCI group, by a margin of 21% versus 14%.

In a multivariate regression analysis, the strongest predictors of MCI in patients across the spectrum of CVD were current smoking, with a 2.5-fold increased risk compared with that of nonsmokers, and atrial fibrillation, with a 1.3-fold increased risk.

Dr. Ball reported having no financial conflicts regarding her study.

bjancin@frontlinemedcom.com

SOURCE: Ball J. et al. AHA 2017, Abstract 16240.

Pages

Recommended Reading

Heart failure risk with individual NSAIDs examined in study
MDedge Neurology
Adaptive servo ventilation cuts atrial fib burden
MDedge Neurology
Dementia prevalence increased in heart failure patients
MDedge Neurology
Cannabis associated with increased risk of heart failure and stroke
MDedge Neurology
New-onset AF boosts bad HFrEF outcomes
MDedge Neurology
Do sleep interventions prevent atrial fibrillation?
MDedge Neurology
Carpal tunnel syndrome may flag cardiac amyloidosis in elderly
MDedge Neurology
MI, stroke risk from HFrEF surpasses HFpEF
MDedge Neurology
Phrenic-nerve stimulator maintains benefits for 18 months
MDedge Neurology
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Neurology